BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34351018)

  • 1. Gastric microbiome in horses with and without equine glandular gastric disease.
    Paul LJ; Ericsson AC; Andrews FM; Keowen ML; Morales Yniguez F; Garza F; Banse HE
    J Vet Intern Med; 2021 Sep; 35(5):2458-2464. PubMed ID: 34351018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field study examining the mucosal microbiome in equine glandular gastric disease.
    Paul LJ; Ericsson AC; Andrews FM; McAdams Z; Keowen ML; St Blanc MP; Banse HE
    PLoS One; 2023; 18(12):e0295697. PubMed ID: 38060520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine gamma herpesvirus presence and viral load are not associated with equine glandular gastric disease.
    Thompson RN; Pearson E; McDonough SP; Iannitti H; Van de Walle GR; Banse H; Perkins GA; Tomlinson JE
    Am J Vet Res; 2024 Jun; 85(6):. PubMed ID: 38484465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study comparing the healthy and diseased equine glandular gastric microbiota sampled with sheathed transendoscopic cytology brushes.
    Voss SJ; McGuinness DH; Weir W; Sutton DGM
    J Equine Vet Sci; 2022 Sep; 116():104002. PubMed ID: 35490972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary and management factors influence the equine gastric microbiome.
    Paul LJ; Ericsson AC; Andrews FM; McAdams Z; Keowen ML; St Blanc MP; Banse HE
    J Am Vet Med Assoc; 2022 Sep; 260(S3):S111-S120. PubMed ID: 36108099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
    Ricord M; Andrews FM; Yñiguez FJM; Keowen M; Garza F; Paul L; Chapman A; Banse HE
    Equine Vet J; 2021 Mar; 53(2):356-363. PubMed ID: 32697849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Equine Gastric Glandular Disease: A Case-Control Study in a Finnish Referral Hospital Population.
    Mönki J; Hewetson M; Virtala AM
    J Vet Intern Med; 2016 Jul; 30(4):1270-5. PubMed ID: 27461724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased adrenocortical response to adrenocorticotropic hormone (ACTH) in sport horses with equine glandular gastric disease (EGGD).
    Scheidegger MD; Gerber V; Bruckmaier RM; van der Kolk JH; Burger D; Ramseyer A
    Vet J; 2017 Oct; 228():7-12. PubMed ID: 29153110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a questionnaire to detect the risk of developing ESGD or EGGD in horses.
    Busechian S; Sgorbini M; Orvieto S; Pisello L; Zappulla F; Briganti A; Nocera I; Conte G; Rueca F
    Prev Vet Med; 2021 Mar; 188():105285. PubMed ID: 33530014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of gastrointestinal inflammatory cell type in equine glandular gastric disease.
    Banse HE; Piero FD; Andrews FM; Garcia-Abarca N; Watanabe TTN
    Am J Vet Res; 2023 Dec; 84(12):. PubMed ID: 38041943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management factors and clinical implications of glandular and squamous gastric disease in horses.
    Sykes BW; Bowen M; Habershon-Butcher JL; Green M; Hallowell GD
    J Vet Intern Med; 2019 Jan; 33(1):233-240. PubMed ID: 30499188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine gastric ulcer syndrome in adult horses.
    van den Boom R
    Vet J; 2022; 283-284():105830. PubMed ID: 35472513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum protein expression in Equine Glandular Gastric Disease (EGGD) induced by phenylbutazone.
    Tesena P; Yingchutrakul Y; Roytrakul S; Wongtawan T; Angkanaporn K
    J Vet Med Sci; 2019 Mar; 81(3):418-424. PubMed ID: 30674748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for equine glandular and squamous gastric disease in show jumping Warmbloods.
    Pedersen SK; Cribb AE; Windeyer MC; Read EK; French D; Banse HE
    Equine Vet J; 2018 Nov; 50(6):747-751. PubMed ID: 29660168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome.
    Bush J; van den Boom R; Franklin S
    Equine Vet J; 2018 Jan; 50(1):34-40. PubMed ID: 28555939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omeprazole and sucralfate on gastrointestinal injury in a fasting/NSAID model.
    Bishop RC; Kemper AM; Wilkins PA; McCoy AM
    Equine Vet J; 2021 Oct; ():. PubMed ID: 34719063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of blood sucrose as a screening test for equine gastric ulcer syndrome (EGUS) in adult horses.
    Hewetson M; Sykes BW; Hallowell GD; Tulamo RM
    Acta Vet Scand; 2017 Mar; 59(1):15. PubMed ID: 28284214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and risk factors for equine glandular and squamous gastric disease in polo horses.
    Banse HE; MacLeod H; Crosby C; Windeyer MC
    Can Vet J; 2018 Aug; 59(8):880-884. PubMed ID: 30104780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five- versus seven-day dosing intervals of extended-release injectable omeprazole in the treatment of equine squamous and glandular gastric disease.
    Sundra T; Kelty E; Rendle D
    Equine Vet J; 2024 Jan; 56(1):51-58. PubMed ID: 36977610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol is superior to combined omeprazole-sucralfate for the treatment of equine gastric glandular disease.
    Varley G; Bowen IM; Habershon-Butcher JL; Nicholls V; Hallowell GD
    Equine Vet J; 2019 Sep; 51(5):575-580. PubMed ID: 30809869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.